Jean-Marc Extra
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
Papers in
-
- Breast Cancer Treatment Studies 25
- Oncology 37
- Cancer Treatment and Pharmacology 22
- HER2/EGFR in Cancer Research 21
- Peptidase Inhibition and Analysis 4
- Co-authors
- Anne Vincent‐SalomonPatrice ViensRoman RouzierMarie-Christine FalcouE. BourstynBernard AsselainFrançois BertucciJerzy Klijanienko
- Journals
- Journal of Clinical Oncology (12 papers)European Journal of Cancer (6 papers)Annals of Oncology (3 papers)Cancer Research (2 papers)Journal of Clinical Medicine (2 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Jean-Marc Extra
48 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 73
- Cancer Research 789
- Oncology 1.0k
- Pathology and Forensic Medicine 357
- Radiology, Nuclear Medicine and Imaging 275
- Obstetrics and Gynecology 80
Countries citing papers authored by Jean-Marc Extra
This map shows the geographic impact of Jean-Marc Extra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean-Marc Extra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean-Marc Extra more than expected).
Fields of papers citing papers by Jean-Marc Extra
This network shows the impact of papers produced by Jean-Marc Extra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean-Marc Extra. The network helps show where Jean-Marc Extra may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jean-Marc Extra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 4 | |
| 2 | 2021 | 4 | |
| 3 | 2019 | 9 | |
| 4 | 2017 | 45 | |
| 5 | 2017 | 6 | |
| 6 | 2016 | 6 | |
| 7 | 2016 | 4 | |
| 8 | 2013 | 16 | |
| 9 | 2012 | 7 | |
| 10 | 2012 | 2 | |
| 11 | Capecitabine after anthracycline and taxane exposure in HER2-negative metastatic breast cancer patients: response, survival and prognostic factors. | 2011 | 15 |
| 12 | 2010 | 210 | |
| 13 | 2010 | 92 | |
| 14 | 2009 | 6 | |
| 15 | 2007 | 106 | |
| 16 | 2006 | 31 | |
| 17 | 2006 | 48 | |
| 18 | 2004 | 17 | |
| 19 | 2002 | 265 | |
| 20 | 2001 | 29 |
About Jean-Marc Extra
Jean-Marc Extra is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Reproductive Medicine and Otorhinolaryngology, having authored 49 papers that have together received 1.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (25 papers), Cancer Treatment and Pharmacology (22 papers), HER2/EGFR in Cancer Research (21 papers), Advanced Breast Cancer Therapies (7 papers), Breast Lesions and Carcinomas (7 papers), Ovarian cancer diagnosis and treatment (4 papers), Peptidase Inhibition and Analysis (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Cancer Research (789 citations), Oncology (1.0k citations), Pathology and Forensic Medicine (357 citations), Radiology, Nuclear Medicine and Imaging (275 citations) and Obstetrics and Gynecology (80 citations). Jean-Marc Extra has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Anne Vincent‐Salomon, Patrice Viens, Roman Rouzier, Marie-Christine Falcou, E. Bourstyn, Bernard Asselain, François Bertucci, Jerzy Klijanienko, Philippe Vielh and Renaud Sabatier. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, Cancer Research and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.